12:00 AM
 | 
Feb 13, 2012
 |  BioCentury  |  Finance

Biotech investor, banker and analyst personnel changes

Venture tracks

James Tyree is retiring as president of Abbott Biotech Ventures Inc., a venture capital arm of Abbott Laboratories...

Read the full 80 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >